Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 30, 2025 16:00 ET | Source: INVENTIVA

Combined General Meeting of May 22, 2025 - Availability of the preparatory documents

Daix (France), New York City (New York, United States), April 30, 2025 – Inventiva (Euronext Paris and Nasdaq: IVA), a clinical-stage biopharmaceutical company focused on the development of oral...
April 29, 2025 01:30 ET | Source: SMCP SA

SMCP - Press Release - 2025 Q1 Sales

Q1 2025 Sales Press release - Paris, April 29th, 2025 Continued growth in Q1 2025, driven by performance in France, EMEA, and wholesale partners Q1 2025 sales at €297m, increasing by 2.6% on...
April 25, 2025 07:00 ET | Source: Nature Conservancy of Canada

Conservation contributors to receive King Charles III Coronation Medals

TORONTO, April 25, 2025 (GLOBE NEWSWIRE) -- To mark Earth Week, the Nature Conservancy of Canada (NCC) proudly announces that several individuals are being awarded the prestigious King Charles III...
April 24, 2025 16:01 ET | Source: INVENTIVA

Inventiva announces the publication in Clinical Gastroenterology and Hepatology of its analysis of new biomarker signatures predictive of histological response in patients with MASH treated with lanifibranor

► Biomarker signatures were developed to predict histological treatment response to lanifibranor treatment in patients with MASH and fibrosis ► The biomarker signatures developed for fibrosis...
April 23, 2025 20:00 ET | Source: HUTCHMED (China) Limited

HUTCHMED Highlights Data to be Presented at AACR Annual Meeting 2025

HONG KONG and SHANGHAI and FLORHAM PARK, N.J., April 24, 2025 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:HCM; HKEX:13) today announces that new and updated data from...
April 15, 2025 16:00 ET | Source: INVENTIVA

Inventiva announces filing of its 2024 Universal Registration Document and 2024 Annual Report on Form 20-F

Daix (France), New York City (New York, United States), April 15, 2025 – Inventiva (Euronext Paris and Nasdaq: IVA) (“Inventiva” or the “Company”), a clinical-stage biopharmaceutical company focused...
April 14, 2025 11:45 ET | Source: LVMH

LVMH shows good resilience in the first quarter of 2025

Paris, April 14, 2025 LVMH Moët Hennessy Louis Vuitton, the world’s leading high-quality products group, recorded revenue of €20.3 billion in the first quarter of 2025. LVMH showed good resilience...
April 13, 2025 21:00 ET | Source: Liberty Gold Corp.

Liberty Gold Provides Update on Spin-Out of Goldstrike/Antimony Ridge Project, Southwest Utah into Specialty American Metals Inc.

VANCOUVER, British Columbia, April 13, 2025 (GLOBE NEWSWIRE) -- Liberty Gold Corp. (TSX:LGD; OTCQX:LGDTF) (“Liberty Gold” or the “Company”) is pleased to provide an update on the “spin-out” process...
April 07, 2025 06:45 ET | Source: Healthcare Realty Trust Incorporated

Healthcare Realty Names Peter A. Scott President and Chief Executive Officer

NASHVILLE, Tenn., April 07, 2025 (GLOBE NEWSWIRE) -- Healthcare Realty Trust Incorporated (NYSE:HR) (“Healthcare Realty” or the “Company”) today announced that its Board of Directors (“Board”) has...
April 01, 2025 17:00 ET | Source: INVENTIVA

Inventiva announces completion of enrollment in the Phase 3 NATiV3 clinical trial of lanifibranor in patients with MASH and advanced fibrosis

Target enrollment exceeded with 1009 patients randomized in the main cohort and 410 patients in the exploratory cohort Topline results from NATiV3 projected in the second half of 2026 and, if...